KR830004309A - β-락타마제 억제제로써의 6β-하이드록시 알킬 페니실란산 유도체 - Google Patents

β-락타마제 억제제로써의 6β-하이드록시 알킬 페니실란산 유도체 Download PDF

Info

Publication number
KR830004309A
KR830004309A KR1019800004041A KR800004041A KR830004309A KR 830004309 A KR830004309 A KR 830004309A KR 1019800004041 A KR1019800004041 A KR 1019800004041A KR 800004041 A KR800004041 A KR 800004041A KR 830004309 A KR830004309 A KR 830004309A
Authority
KR
South Korea
Prior art keywords
carbon atoms
compound
formula
alkyl
phenylsulfonyloxymethyl
Prior art date
Application number
KR1019800004041A
Other languages
English (en)
Other versions
KR840000797B1 (ko
Inventor
스페펜 켈로그 미카엘
Original Assignee
에밀 에이·에이고스티니
화이자 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에밀 에이·에이고스티니, 화이자 인코포레이티드 filed Critical 에밀 에이·에이고스티니
Publication of KR830004309A publication Critical patent/KR830004309A/ko
Priority to KR1019840002245A priority Critical patent/KR840000795B1/ko
Application granted granted Critical
Publication of KR840000797B1 publication Critical patent/KR840000797B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/04—Preparation
    • C07D499/08—Modification of a carboxyl radical directly attached in position 2, e.g. esterification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/74—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with carbocyclic rings directly attached to the carboxamido radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

내용 없음

Description

β-락타마제 억제제로써의 6β-하이드록시 알킬 페니실란산 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 다음 일반식(b)의 화합물에서 벤질그룹을 제거하고 필요하면 그의 약학적으로 무독한 염기성염을 생성하는 것을 특징으로 하여 다음 일반식(a)의 화합물 또는 그의 약학적으로 무독한 염기성 염을 제조하는 방법.
    상기 식에서 Y는 R 또는 R2인데, R은 1-하이드록시-3-페닐프로필, 알킬설포닐옥시메틸(알킬의 탄소수는 1 내지 4), 페닐설포닐옥시메틸 또는 메틸, 메톡시, 플루오로, 클로로, 브로모 또는 트리플루오로메틸로 치환된 페닐설포닐옥시메틸이고; R2는인데
    R3는 설포, 수소, 탄소수 2 내지 4의 알콕시카보닐, 탄소수 2 내지 18인 알카노일, 벤조일, 페닐설포닐, 또는 메틸, 메톡시, 플루오로, 클로로, 브로모, 또는 트리플루오로메틸로 치환된 벤조일 또는 페닐설포닐이며; R4는 수소, 탄소수 1 내지 4의 알킬, 페닐, 벤질 또는 펜에틸이며 n은 0 또는 2이고,
    단 Y가 R일때는 n은 0이며, Y가 R2면 n은 2이어야 한다.
  2. 다음 일반식(a)화합물의 염기성염과 일반식 X-Z 화합물을 반응시키는 것을 특징으로 하여 다음 일반식(C)의 화합물을 제조하는 방법.
    상기식에서 Y는 R 또는 R2인데, R은 1-하이드록시-3-페닐프로필, 알킬설포닐옥시메틸(알킬의 탄소수는 1 내지 4), 페닐설포닐옥시메틸 또는 메틸, 메톡시, 플루오로, 클로로, 브로모 또는 트리플루오로메틸로 치환된 페닐설포닐옥시메틸이고; R2는인데
    R3는 설포, 수소, 탄소수 2 내지 4의 알콕시카보닐, 탄소수 2 내지 18인 알카노일, 벤조일, 페닐설포닐, 또는 메틸, 메톡시, 플루오로, 클로로, 브로모, 또는 트리플루오로메틸로 치환된 벤조일 또는 페닐설포닐이며; R4는 수소, 탄소수 1 내지 4의 알킬, 페닐, 벤질 또는 펜에틸이며 n은 0 또는 2이고,
    Z는 체내에서 쉽게 가수분해될 수 있는 에스테르생성 잔기이며
    X는 할로겐인데, 단, Y가 R일때는 n은 0이며 Y가 R2일때는 n은 2이어야 한다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019800004041A 1979-10-22 1980-10-21 6β-하이드록시알킬페니실란산 유도체의 제조방법 KR840000797B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019840002245A KR840000795B1 (ko) 1980-10-21 1984-04-26 6β-하이드록시알킬 페니실란산 에스테르의 제조방법

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/086,864 US4287181A (en) 1979-10-22 1979-10-22 Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors
US86864 1979-10-22

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1019840002245A Division KR840000795B1 (ko) 1980-10-21 1984-04-26 6β-하이드록시알킬 페니실란산 에스테르의 제조방법

Publications (2)

Publication Number Publication Date
KR830004309A true KR830004309A (ko) 1983-07-09
KR840000797B1 KR840000797B1 (ko) 1984-06-12

Family

ID=22201393

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019800004041A KR840000797B1 (ko) 1979-10-22 1980-10-21 6β-하이드록시알킬페니실란산 유도체의 제조방법

Country Status (38)

Country Link
US (1) US4287181A (ko)
JP (2) JPS5665892A (ko)
KR (1) KR840000797B1 (ko)
AR (1) AR227164A1 (ko)
AT (2) AT369372B (ko)
AU (1) AU519578B2 (ko)
BE (1) BE885812A (ko)
BG (2) BG38639A3 (ko)
CA (2) CA1144159A (ko)
CH (2) CH646175A5 (ko)
CS (2) CS219291B2 (ko)
DD (1) DD154542A5 (ko)
DE (1) DE3039504C2 (ko)
DK (1) DK389480A (ko)
ES (1) ES496166A0 (ko)
FI (1) FI71156C (ko)
FR (1) FR2467852A1 (ko)
GB (3) GB2061930B (ko)
GR (1) GR70714B (ko)
GT (1) GT198065892A (ko)
HU (1) HU183236B (ko)
IE (3) IE51027B1 (ko)
IL (1) IL61307A (ko)
IN (1) IN154918B (ko)
IT (1) IT1149259B (ko)
LU (1) LU82880A1 (ko)
MX (1) MX6094E (ko)
NL (1) NL183358C (ko)
NO (1) NO159019C (ko)
NZ (1) NZ195307A (ko)
PH (5) PH16219A (ko)
PL (2) PL129534B1 (ko)
PT (1) PT71946B (ko)
RO (2) RO81225B (ko)
SE (1) SE451455B (ko)
SU (2) SU1122227A3 (ko)
YU (2) YU41743B (ko)
ZA (1) ZA806452B (ko)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE49768B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
GB2076812A (en) * 1980-05-22 1981-12-09 Ciba Geigy Ag Penam-dioxide compounds, processes for their manufacture, and their use
US4444687A (en) * 1981-06-08 1984-04-24 Bristol-Myers Company 2β-Chloromethyl-2α-methylpenam-3α-carboxylic acid sulfone methylene diol mixed esters
ZA826687B (en) * 1981-09-14 1983-07-27 Pfizer Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl 5(r)penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor
US4351840A (en) 1981-09-18 1982-09-28 Pfizer Inc. Antibacterial esters of resorcinol with ampicillin and penicillanic acid 1,1-dioxide derivatives
JPS58109490A (ja) * 1981-12-21 1983-06-29 Sankyo Co Ltd ペニシリン誘導体
RO87705A (ro) * 1982-01-11 1985-10-31 Pfizer Inc,Us Procedeu pentru prepararea unor derivati ai acidului 6-aminoalchilpenicilanic 1,1-dioxid
US4452796A (en) * 1982-06-14 1984-06-05 Pfizer Inc. 6-Aminoalkylpenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
US4377590A (en) * 1982-05-10 1983-03-22 Pfizer Inc. Derivatives of ampicillin and amoxicillin with beta-lactamase inhibitors
US4502990A (en) * 1983-06-06 1985-03-05 Pfizer Inc. Process for 6-(aminomethyl)penicillanic acid 1,1-dioxide and derivatives thereof
US4588527A (en) * 1983-06-06 1986-05-13 Pfizer Inc. Process for preparing penicillanic acid 1,1-dioxide derivatives
US4536393A (en) * 1983-06-06 1985-08-20 Pfizer Inc. 6-(Aminomethyl)penicillanic acid 1,1-dioxide esters and intermediates therefor
US4499017A (en) * 1983-06-06 1985-02-12 Pfizer Inc. Beta-lactamase inhibiting 6-(alkoxyamino-methyl) penicillanic acid 1,1-dioxide and derivatives
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
US4826833A (en) * 1984-01-30 1989-05-02 Pfizer Inc. 6-(Substituted)methylene-penicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof
EP0150984B1 (en) * 1984-01-30 1991-09-11 Pfizer Inc. 6-(substituted) methylenepenicillanic and 6-(substituted) hydroxymethylpenicillanic acids and derivatives thereof
ES8604972A1 (es) * 1984-01-30 1986-02-16 Pfizer Un procedimiento para la preparacion de acidos 6-metilen-(sustituido) penicilanicos y derivados de los mismos.
US5015473A (en) * 1984-01-30 1991-05-14 Pfizer Inc. 6-(substituted)methylenepenicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof
US4503040A (en) * 1984-02-27 1985-03-05 Pfizer Inc. 6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lactamase inhibitors
US4847247A (en) * 1984-07-30 1989-07-11 Merck & Co., Inc. Penicillin derivatives as anti-inflammatory and antidegenerative agents
US4590073A (en) * 1984-10-22 1986-05-20 Pfizer Inc. 6-substituted penicillanic acid 1,1-dioxide compounds
US4591459A (en) * 1984-12-03 1986-05-27 Pfizer Inc. Intermediates for 6-(aminoacyloxymethyl) penicillanic acid 1,1-dioxides
US4675186A (en) 1985-04-18 1987-06-23 Pfizer Inc. 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives
US4762921A (en) * 1985-04-18 1988-08-09 Pfizer Inc. 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives
US4613462A (en) * 1985-07-02 1986-09-23 Pfizer, Inc. 6-substituted penicillanic acid 1,1-dioxide compounds
US4782050A (en) * 1987-01-27 1988-11-01 Pfizer Inc. 6-beta(substituted)-(S)-hydroxymethylpenicillanic acids and derivatives thereof
ES2031589T3 (es) * 1987-01-27 1992-12-16 Pfizer Inc. Acidos 6-beta-(sustituyente)-(s)-hidroximetil-penicilanicos y sus derivados.
US6395726B1 (en) 1999-01-26 2002-05-28 American Cyanamid Company 3,6-disubstituted penam sulfone derivatives
PA8579701A1 (es) * 2002-08-23 2005-05-24 Pfizer Prod Inc Profarmaco inhibidor de beta-lactamasa
CA2528065A1 (en) * 2003-06-05 2004-12-16 Pfizer Products Inc. Beta-lactamase inhibitor prodrug
ES2398258T3 (es) * 2007-03-09 2013-03-14 Otsuka Chemical Co., Ltd. Procedimiento para producir un compuesto 6-hidroxieltil penam
CN109422765B (zh) * 2017-09-05 2020-08-28 香港理工大学深圳研究院 C类β-内酰胺酶抑制剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5749555B2 (ko) * 1973-04-04 1982-10-22
US4207323A (en) * 1975-11-21 1980-06-10 Merck & Co., Inc. 6-Substituted methyl penicillins, derivatives and analogues thereof
US4053468A (en) * 1976-02-25 1977-10-11 Smithkline Corporation Process for preparing 7-oxo cephalosporins and 6-oxo penicillins
US4093625A (en) * 1976-08-09 1978-06-06 Massachusetts Institute Of Technology 6-Sulfur analogs of penicillins and cephalosporins
US4123539A (en) * 1977-12-29 1978-10-31 Merck & Co., Inc. 6-Ethylpenicillanic acid
US4272439A (en) * 1978-06-02 1981-06-09 Schering Corporation 6-(Substituted-hydroxymethylene penams)
JPS5598186A (en) * 1979-01-10 1980-07-25 Beecham Group Ltd Manufacture of penicillin derivative
GB2076812A (en) * 1980-05-22 1981-12-09 Ciba Geigy Ag Penam-dioxide compounds, processes for their manufacture, and their use

Also Published As

Publication number Publication date
AT369372B (de) 1982-12-27
NL8005810A (nl) 1981-04-24
FI71156B (fi) 1986-08-14
FI803311L (fi) 1981-04-23
BG38639A3 (en) 1986-01-15
AR227164A1 (es) 1982-09-30
FR2467852B1 (ko) 1983-10-07
PH17317A (en) 1984-07-20
PH16219A (en) 1983-08-09
GB2128986B (en) 1985-06-19
NO803136L (no) 1981-04-23
PH17458A (en) 1984-08-29
BG35189A3 (en) 1984-02-15
CH646175A5 (fr) 1984-11-15
IT8025488A0 (it) 1980-10-21
IE51027B1 (en) 1986-09-17
DK389480A (da) 1981-04-23
GB2129421A (en) 1984-05-16
GB8316829D0 (en) 1983-07-27
SU1026654A3 (ru) 1983-06-30
DD154542A5 (de) 1982-03-31
IE850293L (en) 1981-04-22
IN154918B (ko) 1984-12-22
RO81225A (ro) 1983-02-15
NO159019C (no) 1988-11-23
CA1144159A (en) 1983-04-05
GB8316830D0 (en) 1983-07-27
YU41743B (en) 1987-12-31
GB2129421B (en) 1984-11-14
GB2061930B (en) 1984-06-13
IL61307A (en) 1984-03-30
YU42075B (en) 1988-04-30
FI71156C (fi) 1986-11-24
PT71946B (en) 1981-08-31
US4287181A (en) 1981-09-01
CH647242A5 (fr) 1985-01-15
JPS5665892A (en) 1981-06-03
AU6354880A (en) 1981-04-30
IE852229L (en) 1981-04-22
MX6094E (es) 1984-11-12
JPS61178988A (ja) 1986-08-11
SE451455B (sv) 1987-10-12
IL61307A0 (en) 1980-12-31
KR840000797B1 (ko) 1984-06-12
AT374479B (de) 1984-04-25
CA1163924A (en) 1984-03-20
NO159019B (no) 1988-08-15
GR70714B (ko) 1983-01-18
RO86176A (ro) 1985-03-15
RO81225B (ro) 1983-02-28
NL183358B (nl) 1988-05-02
GB2061930A (en) 1981-05-20
PL235907A1 (ko) 1982-09-13
SU1122227A3 (ru) 1984-10-30
YU267680A (en) 1983-09-30
DE3039504C2 (de) 1984-10-11
PT71946A (en) 1980-11-01
FR2467852A1 (fr) 1981-04-30
PH17315A (en) 1984-07-20
IT1149259B (it) 1986-12-03
IE802174L (en) 1981-04-22
YU67183A (en) 1984-02-29
PL227420A1 (ko) 1982-08-30
JPS6135197B2 (ko) 1986-08-12
HU183236B (en) 1984-04-28
DE3039504A1 (de) 1981-04-30
ATA518580A (de) 1982-05-15
NL183358C (nl) 1988-10-03
ATA10882A (de) 1983-09-15
ES8204437A1 (es) 1982-05-01
CS219292B2 (en) 1983-03-25
IE51026B1 (en) 1986-09-17
ES496166A0 (es) 1982-05-01
IE51028B1 (en) 1986-09-17
GT198065892A (es) 1982-04-10
PL129534B1 (en) 1984-05-31
PH18316A (en) 1985-05-29
CS219291B2 (en) 1983-03-25
LU82880A1 (fr) 1981-06-04
AU519578B2 (en) 1981-12-10
BE885812A (fr) 1981-04-21
ZA806452B (en) 1981-10-28
GB2128986A (en) 1984-05-10
NZ195307A (en) 1984-08-24
PL129638B1 (en) 1984-05-31
SE8007354L (sv) 1981-04-23
RO86176B (ro) 1985-03-31

Similar Documents

Publication Publication Date Title
KR830004309A (ko) β-락타마제 억제제로써의 6β-하이드록시 알킬 페니실란산 유도체
KR850000406A (ko) 4-클로로-2-페닐이미다졸-5-아세트산유도체의 제조방법
KR870000322A (ko) 피리돈 카복실산 유도체의 제조방법
KR890014435A (ko) 페녹시알킬카복실산 유도체 및 이의 제조방법
KR870003994A (ko) 도파민-β-하이드록시라제 억제제
IE790996L (en) Phenylaminothiophene derivatives
ES421067A1 (es) Procedimiento para la preparacion de nuevas 2-fenilamino- imidazolinas sustituidas.
KR830001915A (ko) 이소티아졸린을 함유하는 아조 화합물의 제조방법
KR860008983A (ko) 4- 벤조일-1- 알킬(알켄일) 피라졸의 제조방법
KR830001952A (ko) 세펄옥심(Cefuroxim)의 제조방법
DK316589A (da) Substituerede azacyclohexylderivater af rifamyciner
KR830005225A (ko) 데오필린의 피페라진 유도체의 제조방법
KR830003415A (ko) 15-설폰 아미도 프로스타글란딘 유도체
KR840001160A (ko) 벤조디옥산-이미다졸린 유도체의 제조방법
KR830003460A (ko) 면역조절 활성을 갖는 치환된 피페라진 및 피페리딘
KR850003407A (ko) 유기인산 에스테르 유도체의 제조방법
KR830005188A (ko) 혈당강하성 구아닐 아미딘의 제조방법
KR830001899A (ko) 4-아미노-3-퀴놀린카복실산 및 에스테르-항분비, 항궤양 화합물
KR830009044A (ko) 3,5-디-3급부틸-4-하이드록시페닐-치환 복소환 화합물의 제조방법
KR850005411A (ko) α-메틸-(6-펜옥시)-2- 피콜릴 사이클로프로판 카복실 레이트의 제조방법
KR860008965A (ko) 1,3-프로판디온 유도체를 제조하는 방법
DE3268984D1 (en) Imidazolylcarboxylic acids, their derivatives and production
KR840006631A (ko) 5-(2-알콕시-3-치환된 페닐) 히단토인의 제조방법
KR830007545A (ko) 프로스타글란딘의 제조방법
KR830004374A (ko) 수용성 아조 화합물 및 이들염의 제조방법